Bio-Rad Laboratories, Inc. Share Price
Stocks
BIO
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 314.46 USD | -0.61% |
|
+4.48% | +3.79% |
| 01/07 | Activist investors make bigger push for campaigns in H1, seek more M&A | RE |
| 03/06 | Bio-Rad Laboratories, Inc. Presents at Jefferies Global Healthcare Conference 2026, Jun-03-2026 08:45 AM |
| Market Cap | 843.14Cr 740.53Cr 688.67Cr 631.95Cr 1.19TCr 81TCr 1.21TCr 8.18TCr 3.19TCr 40TCr 3.17TCr 3.1TCr 1,38000Cr | P/E 2026 * |
37.8x | P/E 2027 * | 37x |
|---|---|---|---|---|---|
| Enterprise Value | 768.24Cr 674.74Cr 627.5Cr 575.81Cr 1.08TCr 74TCr 1.1TCr 7.45TCr 2.91TCr 36TCr 2.88TCr 2.82TCr 1,25800Cr | EV / Sales 2026 * |
2.99x | EV / Sales 2027 * | 2.83x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -0.61% | ||
| 1 week | +4.48% | ||
| Current month | +7.10% | ||
| 1 month | +16.33% | ||
| 3 months | +11.74% | ||
| 6 months | +6.03% | ||
| Current year | +3.79% |
| 1 week | 285.39 |  | 318.7 |
| 1 month | 280.78 | | 318.7 |
| Current year | 236.73 | | 328.56 |
| 1 year | 236.73 | | 343.12 |
| 3 years | 211.43 | | 431.79 |
| 5 years | 211.43 | | 832.7 |
| 10 years | 142.06 | | 832.7 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 01/01/2003 |
| President | 61 | 09/09/2024 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 15/04/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 01/01/2012 |
Jeffrey Edwards
BRD | Director/Board Member | 73 | 25/04/2017 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 25/04/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 11/05/26 | Sell | Executive/Senior Manager | -550 | 0.0025% | ||
| 24/04/26 | Fiscal year | General Counsel | 449 | 0.0020% | ||
| 24/04/26 | Fiscal year | Chief Financial Officer | 2,576 | 0.0117% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.61% | +4.48% | +22.32% | -24.08% | 843.14Cr | |
| +2.29% | +4.28% | -18.10% | -9.83% | 18TCr | |
| +1.46% | -0.42% | -9.56% | -6.46% | 10TCr | |
| +1.58% | +0.62% | +5.61% | +60.91% | 5.94TCr | |
| -1.13% | -1.96% | +32.11% | +56.38% | 5.07TCr | |
| +2.22% | -2.23% | -14.36% | -40.96% | 4.21TCr | |
| +2.98% | -5.74% | - | - | 3.18TCr | |
| +1.50% | -8.26% | -17.23% | -45.22% | 2.72TCr | |
| -7.67% | -9.45% | +44.38% | -13.02% | 2.51TCr | |
| +1.63% | -3.19% | -5.06% | -7.76% | 2.05TCr | |
| Average | +0.25% | -2.57% | +4.46% | -3.34% | 5.46TCr | |
| Weighted average by Cap. | +1.13% | -1.41% | -4.07% | +0.83% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 256.72Cr 225.47Cr 209.69Cr 192.41Cr 361.53Cr 25TCr 367.11Cr 2.49TCr 972.8Cr 12TCr 963.72Cr 942.95Cr 42TCr | 263.48Cr 231.41Cr 215.21Cr 197.48Cr 371.06Cr 25TCr 376.78Cr 2.56TCr 998.43Cr 12TCr 989.1Cr 967.79Cr 43TCr |
| Net income | 22Cr 20Cr 18Cr 17Cr 32Cr 2.17TCr 32Cr 218.08Cr 85Cr 1.06TCr 84Cr 83Cr 3.68TCr | 23Cr 20Cr 19Cr 17Cr 32Cr 2.21TCr 33Cr 222.81Cr 87Cr 1.09TCr 86Cr 84Cr 3.76TCr |
| Net Debt | -75Cr -66Cr -61Cr -56Cr -105.48Cr -7.21TCr -107.11Cr -726.49Cr -283.83Cr -3.55TCr -281.18Cr -275.12Cr -12TCr | -97Cr -85Cr -79Cr -72Cr -135.96Cr -9.3TCr -138.05Cr -936.38Cr -365.84Cr -4.57TCr -362.42Cr -354.61Cr -16TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 25/26/25 | $314.46 | -0.61% | 3,55,483 |
| 23/26/23 | $316.38 | +3.41% | 3,52,751 |
| 22/26/22 | $305.96 | +1.41% | 2,75,067 |
| 21/26/21 | $301.70 | -0.07% | 3,02,880 |
| 20/26/20 | $301.90 | -0.81% | 4,54,218 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
Select your edition
All financial news and data tailored to specific country editions
